MPM BioVentures 2014, L.P. - Insider Trading & Ownership

Location
C/O Mpm Asset Management Llc, 450 Kendall Street, Cambridge, MA
Summary
The estimated value of insider holdings of MPM BioVentures 2014, L.P. is at least $110M dollars as of December 1, 2025. MPM BioVentures 2014, L.P. is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $88.6M. MPM BioVentures 2014, L.P. is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $17M. MPM BioVentures 2014, L.P. is the 10%+ Owner of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $4.68M.
Signature
/s/ Ansbert Gadicke, Managing Director of MPM BioVentures 2014 LLC, the manager of MPM Asset Management Investors BV2014 LLC
All Insider Reports
All Insider Reports

Ownership of MPM BioVentures 2014, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRDA Entrada Therapeutics, Inc. 10%+ Owner $88.6M -$917K -1.02% Dec 10, 2024
ITOS iTeos Therapeutics, Inc. Former 10% Owner $17M -$5.08M -23% May 13, 2025
HOWL Werewolf Therapeutics, Inc. 10%+ Owner $4.68M -$2.04M -30.4% Nov 26, 2025
TCRR TCR2 THERAPEUTICS INC. 10%+ Owner Jun 1, 2023

Insider Transactions Reported by MPM BioVentures 2014, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.